Search

International audience; Spondyloarthropathies are associated with a greater cardiovascular risk than expected based on the cardiac lesions known to occur in these diseases. The prevalence of several conventional risk factors is high in spondyloarthropathy patients, and chronic inflammation also contributes to premature plaque formation. In addition, susceptibility genes for spondyloarthropathies may be associated with an increased risk of cardiovascular disease. Finally, several drugs used to treat spondyloarthropathies may contribute to the occurrence of cardiovascular events. A careful evaluation of the cardiovascular risk profile is a key component of the management of patients with spondyloarthropathies.

Resume On objective au sein des spondylarthropathies une surmortalite cardiovasculaire que les atteintes cardiaques classiques n’expliquent pas. Il existe chez ces patients une prevalence accrue de certains facteurs de risque conventionnels et une inflammation chronique a l’origine d’une formation precoce de plaques d’atherome. Les patients atteints de spondylarthropathies presentent egalement un risque cardiovasculaire specifique lie probablement au terrain genetique. De plus, certaines therapeutiques ont pu etre incriminees dans la survenue d’evenements cardiovasculaires indesirables. L’evaluation: Du risque cardiovasculaire chez ces patients apparait donc opportune au cours de leur suivi.